Concepts (129)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Renal Dialysis | 6 | 2017 | 124 | 1.710 |
Why?
|
| Kidney Failure, Chronic | 10 | 2017 | 239 | 1.340 |
Why?
|
| Renal Insufficiency, Chronic | 2 | 2018 | 188 | 0.600 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2018 | 90 | 0.550 |
Why?
|
| Hypernatremia | 1 | 2017 | 10 | 0.530 |
Why?
|
| Electric Conductivity | 1 | 2017 | 55 | 0.530 |
Why?
|
| Population Groups | 2 | 2014 | 59 | 0.430 |
Why?
|
| Cardiovascular Diseases | 3 | 2018 | 729 | 0.420 |
Why?
|
| Ambulatory Care Facilities | 1 | 2014 | 65 | 0.410 |
Why?
|
| Appointments and Schedules | 2 | 2014 | 27 | 0.380 |
Why?
|
| Patient Compliance | 1 | 2014 | 225 | 0.380 |
Why?
|
| Glomerular Filtration Rate | 4 | 2008 | 144 | 0.370 |
Why?
|
| Heart Failure | 2 | 2007 | 298 | 0.350 |
Why?
|
| Aged | 15 | 2017 | 7982 | 0.330 |
Why?
|
| Kidney Diseases | 3 | 2008 | 170 | 0.290 |
Why?
|
| Coronary Disease | 2 | 2010 | 123 | 0.290 |
Why?
|
| Treatment Refusal | 1 | 2008 | 23 | 0.290 |
Why?
|
| Aged, 80 and over | 6 | 2017 | 2803 | 0.250 |
Why?
|
| Middle Aged | 16 | 2018 | 11819 | 0.230 |
Why?
|
| Troponin T | 1 | 2004 | 10 | 0.220 |
Why?
|
| Referral and Consultation | 1 | 2005 | 141 | 0.220 |
Why?
|
| Arteriovenous Shunt, Surgical | 1 | 2003 | 4 | 0.210 |
Why?
|
| Male | 17 | 2018 | 22779 | 0.200 |
Why?
|
| Catheters, Indwelling | 1 | 2003 | 9 | 0.200 |
Why?
|
| Humans | 21 | 2018 | 42163 | 0.200 |
Why?
|
| Retrospective Studies | 5 | 2014 | 2485 | 0.190 |
Why?
|
| Hyperkalemia | 1 | 2002 | 13 | 0.190 |
Why?
|
| Diuretics | 1 | 2002 | 51 | 0.190 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2002 | 78 | 0.190 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2003 | 77 | 0.190 |
Why?
|
| Spironolactone | 1 | 2002 | 36 | 0.190 |
Why?
|
| Warfarin | 1 | 2003 | 66 | 0.190 |
Why?
|
| Nephrosclerosis | 1 | 2002 | 6 | 0.190 |
Why?
|
| Thrombosis | 1 | 2003 | 81 | 0.190 |
Why?
|
| Hypertension, Renal | 1 | 2002 | 16 | 0.180 |
Why?
|
| Nephrotic Syndrome | 1 | 2002 | 11 | 0.180 |
Why?
|
| Aspirin | 1 | 2003 | 88 | 0.180 |
Why?
|
| Proteinuria | 1 | 2002 | 55 | 0.180 |
Why?
|
| Anticoagulants | 1 | 2003 | 121 | 0.180 |
Why?
|
| Socioeconomic Factors | 1 | 2005 | 1221 | 0.180 |
Why?
|
| Adult | 12 | 2014 | 13458 | 0.160 |
Why?
|
| Disease Progression | 2 | 2018 | 661 | 0.160 |
Why?
|
| Female | 15 | 2014 | 24018 | 0.160 |
Why?
|
| Treatment Outcome | 3 | 2018 | 1586 | 0.150 |
Why?
|
| Vitamin D Deficiency | 1 | 2018 | 107 | 0.130 |
Why?
|
| Iatrogenic Disease | 1 | 2017 | 7 | 0.130 |
Why?
|
| Vitamin D | 1 | 2018 | 196 | 0.130 |
Why?
|
| Hospitalization | 2 | 2014 | 482 | 0.120 |
Why?
|
| Mass Screening | 2 | 2010 | 531 | 0.110 |
Why?
|
| Renal Insufficiency | 1 | 2014 | 19 | 0.100 |
Why?
|
| United States | 5 | 2018 | 5072 | 0.100 |
Why?
|
| Oxidative Stress | 1 | 2018 | 990 | 0.100 |
Why?
|
| Time Factors | 2 | 2008 | 1848 | 0.090 |
Why?
|
| Risk Factors | 5 | 2010 | 3942 | 0.090 |
Why?
|
| Prevalence | 3 | 2018 | 1597 | 0.090 |
Why?
|
| Prospective Studies | 2 | 2008 | 1574 | 0.090 |
Why?
|
| Indians, North American | 1 | 2014 | 179 | 0.090 |
Why?
|
| Kidney Function Tests | 1 | 2010 | 30 | 0.090 |
Why?
|
| Risk Reduction Behavior | 1 | 2010 | 137 | 0.080 |
Why?
|
| Community Networks | 2 | 2006 | 106 | 0.070 |
Why?
|
| Hypertension | 2 | 2006 | 823 | 0.070 |
Why?
|
| Georgia | 2 | 2006 | 189 | 0.070 |
Why?
|
| Infant, Low Birth Weight | 1 | 2007 | 36 | 0.070 |
Why?
|
| Regression Analysis | 1 | 2008 | 487 | 0.060 |
Why?
|
| Nutrition Surveys | 1 | 2008 | 263 | 0.060 |
Why?
|
| Anemia | 1 | 2007 | 52 | 0.060 |
Why?
|
| Societies, Medical | 1 | 2006 | 74 | 0.060 |
Why?
|
| Comorbidity | 2 | 2005 | 725 | 0.060 |
Why?
|
| Nephrology | 1 | 2005 | 19 | 0.060 |
Why?
|
| Unemployment | 1 | 2005 | 27 | 0.060 |
Why?
|
| Registries | 2 | 2005 | 431 | 0.060 |
Why?
|
| Myocardial Infarction | 1 | 2008 | 242 | 0.060 |
Why?
|
| Serum Albumin | 1 | 2005 | 58 | 0.060 |
Why?
|
| Medically Underserved Area | 1 | 2005 | 118 | 0.060 |
Why?
|
| Coronary Angiography | 1 | 2004 | 97 | 0.050 |
Why?
|
| Educational Status | 1 | 2005 | 335 | 0.050 |
Why?
|
| Stroke | 1 | 2008 | 348 | 0.050 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2005 | 225 | 0.050 |
Why?
|
| Urban Population | 1 | 2005 | 364 | 0.050 |
Why?
|
| Education, Medical | 1 | 2005 | 117 | 0.050 |
Why?
|
| Predictive Value of Tests | 1 | 2004 | 438 | 0.050 |
Why?
|
| Equipment Failure | 1 | 2003 | 12 | 0.050 |
Why?
|
| Sex Factors | 2 | 2007 | 1008 | 0.050 |
Why?
|
| Cooperative Behavior | 1 | 2005 | 250 | 0.050 |
Why?
|
| Schools, Medical | 1 | 2005 | 208 | 0.050 |
Why?
|
| Diabetic Nephropathies | 1 | 2003 | 74 | 0.050 |
Why?
|
| Treatment Failure | 1 | 2002 | 61 | 0.050 |
Why?
|
| Creatinine | 1 | 2002 | 102 | 0.050 |
Why?
|
| Poverty | 1 | 2005 | 395 | 0.050 |
Why?
|
| Alcoholism | 1 | 2005 | 292 | 0.050 |
Why?
|
| Drug Therapy, Combination | 1 | 2002 | 233 | 0.050 |
Why?
|
| Delivery of Health Care | 1 | 2005 | 309 | 0.050 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2002 | 196 | 0.040 |
Why?
|
| Kidney Tubules | 1 | 2002 | 38 | 0.040 |
Why?
|
| Logistic Models | 1 | 2004 | 1001 | 0.040 |
Why?
|
| Biopsy | 1 | 2002 | 176 | 0.040 |
Why?
|
| Survival Analysis | 1 | 2002 | 362 | 0.040 |
Why?
|
| Kidney Glomerulus | 1 | 2002 | 85 | 0.040 |
Why?
|
| Minority Groups | 2 | 2005 | 663 | 0.040 |
Why?
|
| Health Promotion | 1 | 2006 | 691 | 0.040 |
Why?
|
| Length of Stay | 1 | 2002 | 231 | 0.040 |
Why?
|
| Kidney | 1 | 2002 | 363 | 0.040 |
Why?
|
| Health Services Accessibility | 1 | 2005 | 680 | 0.040 |
Why?
|
| Early Diagnosis | 2 | 2010 | 69 | 0.040 |
Why?
|
| Incidence | 1 | 2002 | 1054 | 0.040 |
Why?
|
| Prognosis | 1 | 2002 | 850 | 0.040 |
Why?
|
| Age Factors | 1 | 2002 | 1139 | 0.040 |
Why?
|
| Substance-Related Disorders | 1 | 2005 | 825 | 0.030 |
Why?
|
| Aging | 1 | 2002 | 764 | 0.030 |
Why?
|
| Health Surveys | 1 | 2018 | 401 | 0.030 |
Why?
|
| Adolescent | 2 | 2007 | 5950 | 0.030 |
Why?
|
| Community Health Services | 2 | 2008 | 207 | 0.030 |
Why?
|
| Chronic Disease | 2 | 2008 | 541 | 0.030 |
Why?
|
| Primary Health Care | 2 | 2005 | 362 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 1 | 2010 | 62 | 0.020 |
Why?
|
| Foundations | 1 | 2008 | 11 | 0.020 |
Why?
|
| Human Experimentation | 1 | 2008 | 11 | 0.020 |
Why?
|
| South Carolina | 1 | 2006 | 25 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2008 | 336 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2008 | 638 | 0.020 |
Why?
|
| North Carolina | 1 | 2006 | 122 | 0.020 |
Why?
|
| Interprofessional Relations | 1 | 2006 | 56 | 0.020 |
Why?
|
| Group Practice | 1 | 2005 | 8 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2007 | 960 | 0.010 |
Why?
|
| Insurance Coverage | 1 | 2005 | 108 | 0.010 |
Why?
|
| Quality of Health Care | 1 | 2005 | 158 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2005 | 225 | 0.010 |
Why?
|
| Blood Pressure | 1 | 2006 | 662 | 0.010 |
Why?
|
| Antihypertensive Agents | 1 | 2005 | 285 | 0.010 |
Why?
|